Elusys therapeutics nj
WebBiotechnology. Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 1998. Founders Jeff Wolf. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Phone Number 9738080322. Elusys Therapeutics is a privately-held biopharmaceutical company focused on the development of antibody … WebAbout Us. Elusys Therapeutics is a NightHawk Biosciences company that leverages immune-stimulatory and immune-derived therapies to combat infectious disease. Our anthrax antitoxin ANTHIM® (obiltoxaximab) is licensed in the United States, Canada, United Kingdom, and the European Union as a medical countermeasure to mitigate the effect of ...
Elusys therapeutics nj
Did you know?
WebJan 28, 2024 · Deb was born in Ridgewood NJ, grew up in Waldwick and later resided in Butler and also California. She attended Waldwick High School, Rutgers and Fairleigh Dickinson University. Debra retired from a career she loved as Senior Director of Human Resources and Administration at Elusys Therapeutics. WebApr 8, 2014 · Elusys Therapeutics, a private company based in Pine Brook, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. Elusys has been engaged in the ...
WebJan 31, 2024 · About Elusys Therapeutics Elusys, based in Parsippany, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. ANTHIM®(obiltoxaximab) Injection, the ... WebApr 19, 2024 · April 19, 2024 11:00 ET Source: Heat Biologics. DURHAM, N.C., April 19, 2024 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NYSE American: HTBX), a clinical-stage biopharmaceutical ...
WebElusys General Information. Description. Developer of antibody therapeutics designed to treat infectious life-threatening infectious diseases. The company's therapeutics treat anthrax exposure following a natural or intentional release of anthrax spores and also … WebCompany Description: Elusys Therapeutics is recruiting antibodies in its anti-terrorism campaign. The company develops antibody therapies for a variety of targets, including anthrax. Its lead product Anthim was approved by the US FDA in 2016 to treat and …
WebThe Registered Agent on file for this company is Elusys Therapeutics, Inc. and is located at 80 State Street, Albany, NY 12207. The company's principal address is 25 Riverside Drive Po Box 102, Pine Brook, NJ 07058 and its mailing address is 80 State Street, Albany, NY 12207. The company has 1 contact on record.
WebDec 21, 2024 · About Elusys Therapeutics Elusys, based in Parsippany, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease. ANTHIM®(obiltoxaximab) Injection, the ... richmond consolidated school reviewsWebApr 20, 2024 · Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C., April 20, 2024 (GLOBE... richmond consolidated school maWebElusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases.[1] The antibodies are developed from protein complexes called … richmond consolidated school calendarWebBiotechnology. Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 1998. Founders Jeff Wolf. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Phone Number 9738080322. Elusys … richmond consolidated school richmond maWebFeb 21, 2024 · Glenda Teitel is an Associate Director, Finance at Elusys Therapeutics based in Parsippany, New Jersey. Previously, Glenda was a Manager, Accounting at Integra LifeSciences and also held positions at Berlitz, Quest Diagnostics. Glenda received a High School degree from Pennsauken High School and a Bachelor of Science from … red river meeting house adairville kyWebHe has spent nearly 30 years in pharmaceuticals serving as the CFO or top finance executive at seven of those companies (Searle, Reliant, Savient, … red river memorial day runWebElusys Therapeutics is a subsidiary of NightHawk Biosciences, an ecosystem of companies dedicated to developing and deploying novel biodefense solutions to enable fast, effective, and durable treatment and protection against infectious agents. The NightHawk … Elusys was also contracted as of 2024 to deliver ANTHIM to the Public Health … Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys … The following resources contain information regarding anthrax infection, guidelines … Please call 1-844-808-0222 or email [email protected] General … At Emergo Therapeutics he worked on a novel immunological treatment for … Prior to that from 1982-1985, he was Research Group Chief, Department of … David F. Lasseter was the Deputy Assistant Secretary of Defense for Countering … Elusys Publications. Nighthawk Publications. 2024. ... September 2016 … red river metis coin